EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial
- PMID: 22617866
- PMCID: PMC3939717
- DOI: 10.1177/1087054712446173
EEG neurofeedback for ADHD: double-blind sham-controlled randomized pilot feasibility trial
Abstract
Objective: Preparing for a definitive randomized clinical trial (RCT) of neurofeedback (NF) for ADHD, this pilot trial explored feasibility of a double-blind, sham-controlled design and adherence/palatability/relative effect of two versus three treatments/week.
Method: Unmedicated 6- to 12-year-olds with Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) ADHD were randomized to active NF versus sham-NF and to 2X versus 3X/week treatment frequency. Frequency switch was allowed after Treatment 24.
Results: In two school years, 39 participants were recruited and 34 (87%) completed all 40 treatments. Child/parent guesses about assigned treatment were no better than chance. At Treatment 24, 38% chose 2X/week and 62% chose 3X/week. Both active NF and sham yielded large pre-post improvement on parent ratings but NF no more than sham.
Conclusion: Blinding appears to work, and sham does not prevent recruitment/retention. Treatment frequency of 3X/week seems preferred over 2X/week and was as effective. A large double-blind RCT is feasible and necessary to test specific NF effectiveness.
Keywords: ADHD; adolescent; neurofeedback.
Figures




Similar articles
-
A proposed multisite double-blind randomized clinical trial of neurofeedback for ADHD: need, rationale, and strategy.J Atten Disord. 2013 Jul;17(5):420-36. doi: 10.1177/1087054713482580. Epub 2013 Apr 16. J Atten Disord. 2013. PMID: 23590978 Clinical Trial.
-
A randomized placebo-controlled trial of electroencephalographic (EEG) neurofeedback in children with attention-deficit/hyperactivity disorder.J Clin Psychiatry. 2013 Aug;74(8):821-7. doi: 10.4088/JCP.12m08321. J Clin Psychiatry. 2013. PMID: 24021501 Clinical Trial.
-
ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study.J Neural Transm (Vienna). 2011 Feb;118(2):275-84. doi: 10.1007/s00702-010-0524-2. Epub 2010 Dec 17. J Neural Transm (Vienna). 2011. PMID: 21165661 Free PMC article. Clinical Trial.
-
Current status of neurofeedback for attention-deficit/hyperactivity disorder.Curr Psychiatry Rep. 2012 Oct;14(5):536-42. doi: 10.1007/s11920-012-0301-z. Curr Psychiatry Rep. 2012. PMID: 22890816 Review.
-
Does EEG-neurofeedback improve neurocognitive functioning in children with attention-deficit/hyperactivity disorder? A systematic review and a double-blind placebo-controlled study.J Child Psychol Psychiatry. 2014 May;55(5):460-72. doi: 10.1111/jcpp.12143. Epub 2013 Oct 30. J Child Psychol Psychiatry. 2014. PMID: 24168522 Clinical Trial.
Cited by
-
Clinical utility of EEG in attention-deficit/hyperactivity disorder: a research update.Neurotherapeutics. 2012 Jul;9(3):569-87. doi: 10.1007/s13311-012-0131-z. Neurotherapeutics. 2012. PMID: 22814935 Free PMC article. Review.
-
Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis.Eur Child Adolesc Psychiatry. 2019 Mar;28(3):293-305. doi: 10.1007/s00787-018-1121-4. Epub 2018 Feb 14. Eur Child Adolesc Psychiatry. 2019. PMID: 29445867 Free PMC article.
-
What learning theories can teach us in designing neurofeedback treatments.Front Hum Neurosci. 2014 Nov 6;8:894. doi: 10.3389/fnhum.2014.00894. eCollection 2014. Front Hum Neurosci. 2014. PMID: 25414659 Free PMC article.
-
Cross-frequency neuromodulation: leveraging theta-gamma coupling for cognitive rehabilitation in MCI patients.Front Aging Neurosci. 2025 Apr 30;17:1541126. doi: 10.3389/fnagi.2025.1541126. eCollection 2025. Front Aging Neurosci. 2025. PMID: 40370751 Free PMC article.
-
Better than sham? A double-blind placebo-controlled neurofeedback study in primary insomnia.Brain. 2017 Apr 1;140(4):1041-1052. doi: 10.1093/brain/awx011. Brain. 2017. PMID: 28335000 Free PMC article. Clinical Trial.
References
-
- Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2 ed Lawrence Earlbaum Associates; Hillsdale, NJ: 1988.
-
- Arnold LE. Contemporary Diagnosis and Management of ADHD. 3 ed Handbooks in Health Care Co; Newton, PA: 2004.
-
- Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. American Journal of Psychiatry. 2002;159:1896. - PubMed
-
- Swanson J, Kraemer H, Hinshaw S, Arnold L, Conners C, Abikoff H, et al. Clinical Relevance of the Primary Findings of the MTA: Success Rates Based on Severity of ADHD and ODD Symptoms at the End of Treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40:168–179. - PubMed
-
- Kamiya J. Conscious control of brain waves. Psychology Today. 1968:57–60.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical